wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47588862-34E271F5-D734-4828-933B-4D8AD5391CC2
Q47588862-34E271F5-D734-4828-933B-4D8AD5391CC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47588862-34E271F5-D734-4828-933B-4D8AD5391CC2
Albiglutide efficacy and safety in the Latino/Hispanic subpopulation for the integrated phase III program.
P2860
Q47588862-34E271F5-D734-4828-933B-4D8AD5391CC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47588862-34E271F5-D734-4828-933B-4D8AD5391CC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9f7fafcbdd71e118f2d91dc375d11c588a36236
P2860
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.